These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9930732)

  • 41. Common and reversible regulation of wild-type p53 function and of ribosomal biogenesis by protein kinases in human cells.
    David-Pfeuty T; Nouvian-Dooghe Y; Sirri V; Roussel P; Hernandez-Verdun D
    Oncogene; 2001 Sep; 20(42):5951-63. PubMed ID: 11593402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine.
    Schulze-Gahmen U; Brandsen J; Jones HD; Morgan DO; Meijer L; Vesely J; Kim SH
    Proteins; 1995 Aug; 22(4):378-91. PubMed ID: 7479711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine.
    Buraei Z; Anghelescu M; Elmslie KS
    Biophys J; 2005 Sep; 89(3):1681-91. PubMed ID: 15951378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.
    Diwan P; Lacasse JJ; Schang LM
    J Virol; 2004 Sep; 78(17):9352-65. PubMed ID: 15308730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of three proteins in the eye of Aplysia, whose synthesis is altered by serotonin (5-HT). Possible involvement of these proteins in the ocular circadian system.
    Koumenis C; Nunez-Regueiro M; Raju U; Cook R; Eskin A
    J Biol Chem; 1995 Jun; 270(24):14619-27. PubMed ID: 7782325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cell differentiation, caspase inhibition, and macromolecular synthesis blockage, but not BCL-2 or BCL-XL proteins, protect SH-SY5Y cells from apoptosis triggered by two CDK inhibitory drugs.
    Ribas J; Boix J
    Exp Cell Res; 2004 Apr; 295(1):9-24. PubMed ID: 15051486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemical inhibitors of cyclin-dependent kinases.
    Meijer L
    Prog Cell Cycle Res; 1995; 1():351-63. PubMed ID: 9552377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of cyclin dependent protein kinase inhibitor olomoucine on the neuronal apoptosis after status epilepticus: experiment with rats].
    Du XP; Sun MZ; Yu ZY; Chen HX; Tian DS; Xie MJ; Wang W
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(29):2025-9. PubMed ID: 17925171
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of pharmacological cyclin-dependent kinase inhibitors on viral transcription and replication.
    Schang LM
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):197-209. PubMed ID: 15023361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytokinin-derived cyclin-dependent kinase inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds.
    Havlícek L; Hanus J; Veselý J; Leclerc S; Meijer L; Shaw G; Strnad M
    J Med Chem; 1997 Feb; 40(4):408-12. PubMed ID: 9046330
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence that potassium channels mediate the effects of serotonin on the ocular circadian pacemaker of Aplysia.
    Colwell CS; Michel S; Block GD
    J Comp Physiol A; 1992 Dec; 171(5):651-6. PubMed ID: 1337358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell cycle inhibitor enhances the resolution of HSV-1-induced proinflammatory response in murine microglial cells.
    Zhou Y; Guo YJ; Liu X; Mei YW
    Neurol Res; 2009 Nov; 31(9):910-6. PubMed ID: 19138471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement of a specific protein in the regulation of a circadian rhythm in Aplysia eye.
    Yeung SJ; Eskin A
    Proc Natl Acad Sci U S A; 1987 Jan; 84(1):279-83. PubMed ID: 3025861
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of circadian rhythm on pharmacokinetics and metabolism of the Cdk inhibitor, roscovitine, in tumor mice model.
    Sallam H; El-Serafi AT; Filipski E; Terelius Y; Lévi F; Hassan M
    Chronobiol Int; 2015 Jun; 32(5):608-14. PubMed ID: 25938685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.
    Zhang M; Li J; Chakrabarty P; Bu B; Vincent I
    Am J Pathol; 2004 Sep; 165(3):843-53. PubMed ID: 15331409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Light and serotonin interact in affecting the circadian system of Aplysia.
    Colwell CS
    J Comp Physiol A; 1990 Dec; 167(6):841-5. PubMed ID: 2086792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?
    Wesierska-Gadek J; Krystof V
    Ann N Y Acad Sci; 2009 Aug; 1171():228-41. PubMed ID: 19723060
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of an annexin-like protein and its possible role in the Aplysia eye circadian system.
    Raju U; Nunez-Regueiro M; Cook R; Kaetzel MA; Yeung SC; Eskin A
    J Neurochem; 1993 Oct; 61(4):1236-45. PubMed ID: 8376982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis and biological activity of olomoucine II.
    Krystof V; Lenobel R; Havlícek L; Kuzma M; Strnad M
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3283-6. PubMed ID: 12392733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382.
    Ljungman M; Paulsen MT
    Mol Pharmacol; 2001 Oct; 60(4):785-9. PubMed ID: 11562441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.